| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.1M | +17.2% |
| SG&A Expense | $4.8M | -33.1% |
| Operating Income | -$13.9M | +7.0% |
| Interest Expense | $2.8M | +0.0% |
| Pre-tax Income | -$13.9M | +25.5% |
| Income Tax | $2K | +0.0% |
| Net Income | -$13.9M | +25.5% |
| EPS (Basic) | -$1.28 | +53.3% |
| EPS (Diluted) | -$1.28 |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.8M | -58.1% |
| Current Assets | $4.0M | -56.9% |
| Total Assets | $7.2M | -26.4% |
| Current Liabilities | $979K | +1.0% |
| Total Liabilities | $2.2M | +114.9% |
| Stockholders' Equity | $5.1M | -42.6% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.0M | -7.3% |
| Capital Expenditures | $1.6M | +2890.6% |
| Investing Cash Flow | -$1.6M | -2890.6% |
| Financing Cash Flow | $7.4M | -58.9% |
| Free Cash Flow | -$12.6M | -22.6% |
| +53.3% |